HBM Healthcare Investments Aktie
WKN: 984345 / ISIN: CH0012627250
02.07.2025 06:45:14
|
HBM Healthcare Investments launches new share buyback programme
HBM Healthcare Investments AG
/ Key word(s): Share Buyback
At the Annual General Meeting of HBM Healthcare Investments AG on 23 June 2025, shareholders approved a new share buyback programme for a maximum of 674,000 shares (corresponding to 10% of the shares registered in the commercial register) for the purpose of cancellation through a capital reduction. The buyback programme will be carried out via a separate trading line on the SIX Swiss Exchange, with Zürcher Kantonalbank being entrusted with this task. The programme is scheduled to commence on Friday, 4 July 2025 and is expected to conclude on 3 July 2028 at the latest. Further information on the new 2025 buyback programme is available on the company website at https://www.hbmhealthcare.com/en/investors/information. Contact
End of Media Release |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2163708 |
End of News | EQS News Service |
|
2163708 02.07.2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
01.10.25 |
HBM Healthcare Investments reports strong quarterly results – NAV rises by 16.4 per cent in the second quarter of the 2025/2026 financial year (EQS Group) | |
01.10.25 |
HBM Healthcare Investments erzielt ein starkes Quartalsergebnis – NAV steigt im zweiten Quartal des Geschäftsjahres 2025/2026 um 16,4 Prozent (EQS Group) | |
01.10.25 |
Key Figures 30.09.2025 (EQS Group) | |
29.09.25 |
Genmab übernimmt HBM-Portfoliounternehmen Merus für USD 8 Milliarden in bar (EQS Group) | |
29.09.25 |
Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash (EQS Group) | |
16.09.25 |
Key Figures 15.09.2025 (EQS Group) | |
10.09.25 |
HBM-Portfoliounternehmen Swixx BioPharma und Lundbeck unterzeichnen multiregionale Partnerschaft im Bereich ZNS (EQS Group) | |
10.09.25 |
HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership (EQS Group) |
Analysen zu HBM Healthcare Investments AGmehr Analysen
Aktien in diesem Artikel
HBM Healthcare Investments AG | 199,80 | 2,15% |
|